New study tests monthly day care for advanced cancer patients
NCT ID NCT04604873
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether monthly visits to a hospital day care that includes palliative care can improve quality of life for adults with advanced cancer. 144 patients with a life expectancy between 2 and 12 months took part. Researchers measured changes in quality of life, fatigue, and emotional well-being over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hospital day care follow-up with integrated palliative care
- What this could lead to
- If successful, this approach could show that regular palliative day care helps people with advanced cancer maintain a better quality of life and supports their caregivers.
- What could go wrong
- This is a completed, relatively small study (144 people) without a control group, so results may not apply broadly. It focuses on symptom ease and quality of life, not on extending survival or curing cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER, ADVANCED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
INSTITUT CURIE Saint-Cloud
Saint-Cloud, 92210, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Institut de Cancerologie de L'Ouest
Saint-Herblain, 44805, France
-
Institutcurie Paris
Paris, 75005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.